Pharmacists in Mccall, Idaho


14 Pharmacists found in Mccall
female pharmacist

Amanda Isabel Reguero Valentin, PHARMD


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    

female pharmacist

Andrea Lingle


Pharmacist
1000 State St, Mccall, ID 83638
208-630-2283    

male pharmacist

Andrew Mathes, PHARMD


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    



male pharmacist

Cheyene Joseph Nickerson


Pharmacist
132 East Lake Street, Mccall, ID 83638
208-634-2433    

female pharmacist

Heidi Lee Galyardt, PHARMD


Pharmacist
1000 State St, Mccall, ID 83638
208-630-2283    

male pharmacist

Jason Mitchell Hansen, PHARMD


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    

male pharmacist

Jesse Cook


Pharmacist
1000 State St, Mccall, ID 83638
208-630-2283    

male pharmacist

Karl F Johnson, PHARM D.


Pharmacist
211 Forest St, Mccall, ID 83638
208-630-2568     208-630-2469

male pharmacist

Dr. Kevin Michael Ellis, PHARMD


Pharmacist
132 E Lake St, Mccall, ID 83638
208-634-2433     208-634-3125

male pharmacist

Dr. Lonnie K Huntsinger, PHARM-D


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    

female pharmacist

Mary T Smith, PHARMD


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    

female pharmacist

Megan Hatt, PHARMD


Pharmacist
1000 State St, Mccall, ID 83638
208-630-2283     208-630-2254

female pharmacist

Ms. Sze Wan Chan, RPH


Pharmacist
1001 North 2nd Street, Mccall, ID 83638
208-634-2433    

female pharmacist

Tiffany Jean Oakland, RPH


Pharmacist
451 Deinhard Ln, Mccall, ID 83638
208-634-4929    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.